Literature DB >> 19945452

Comparative proteomic profiling of plasma very-low-density and low-density lipoproteins.

Hung-Yu Sun1, Sun-Fang Chen, Ming-Derg Lai, Ting-Tsung Chang, Tz-Li Chen, Pei-Yu Li, Dar-Bin Shieh, Kung-Chia Young.   

Abstract

BACKGROUND: Low-density lipoprotein (LDL) is a natural metabolite of very-low-density lipoprotein (VLDL) in the circulation. Systematic investigation of total protein components and dynamics might provide insights into this normal metabolic process.
METHODS: VLDL and LDL were purified from normolipidemia pooled plasma by gradient ultracentrifugation with either ionic or non-ionic media. The protein contents were compared by liquid chromatography tandem mass analyses based on isobaric tag for relative and absolute quantitation and two-dimensional gel electrophoresis.
RESULTS: Our comparative lipoproteomes revealed 21 associated proteins. Combined with Western blot analysis, and on the basis of the differential expression levels we classified them into 3 groups: (i) VLDL>LDL [apolipoprotein (apo) A-IV, apo(a), apoCs, apoE, apoJ and serum amyloid A-4]; (ii) VLDL<LDL [albumin, alpha-1-antitrypsin, apoD, apoF, apoM, and paraoxonase-1]; and (iii) VLDL=LDL [apoA-I, apoA-II, apoB-100, apoL-I and prenylcysteine oxidase-1]. The apoA-I level positively correlated with PCYOX1 but negatively with apoM in VLDL and LDL. Furthermore, the two-dimensional maps displayed 5 apoA-I isoforms in which phosphorylation at Ser55, Ser166, Thr185, Thr221 and Ser252 residues were identified.
CONCLUSIONS: This study revealed the VLDL- and LDL lipoproteomes and the full-spectrum protein changes during physiological VLDL-to-LDL transition. It provides a valuable dataset VLDL and LDL proteomes potentially applied to the development of diagnostics. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945452     DOI: 10.1016/j.cca.2009.11.023

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  22 in total

1.  How complicated can it be? The link between APOL1 risk variants and lipoprotein heterogeneity in kidney and cardiovascular diseases.

Authors:  Chien-An A Hu; Patricio E Ray
Journal:  Nephrol Dial Transplant       Date:  2015-10-03       Impact factor: 5.992

2.  Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Authors:  Yan Liu; Richard E Morton
Journal:  Curr Opin Lipidol       Date:  2020-08       Impact factor: 4.776

3.  SAA: a link between cholesterol efflux capacity and inflammation?

Authors:  Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2015-06-15       Impact factor: 5.922

Review 4.  Hepatitis C virus relies on lipoproteins for its life cycle.

Authors:  Germana Grassi; Giorgia Di Caprio; Gian Maria Fimia; Giuseppe Ippolito; Marco Tripodi; Tonino Alonzi
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

5.  Proteomic analysis of electronegative low-density lipoprotein.

Authors:  Cristina Bancells; Francesc Canals; Sònia Benítez; Nuria Colomé; Josep Julve; Jordi Ordóñez-Llanos; José Luis Sánchez-Quesada
Journal:  J Lipid Res       Date:  2010-08-10       Impact factor: 5.922

6.  Analogs of LDL Receptor Ligand Motifs in Dengue Envelope and Capsid Proteins as Potential Codes for Cell Entry.

Authors:  Juan Guevara; Jamie Romo; Troy McWhorter; Natalia Valentinova Guevara
Journal:  J Viruses       Date:  2015

Review 7.  The underlying chemistry of electronegative LDL's atherogenicity.

Authors:  Liang-Yin Ke; Nicole Stancel; Henry Bair; Chu-Huang Chen
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

8.  Identification of Receptor Ligands in Apo B100 Reveals Potential Functional Domains.

Authors:  Juan Guevara; Jamie Romo; Ernesto Hernandez; Natalia Valentinova Guevara
Journal:  Protein J       Date:  2018-12       Impact factor: 2.371

9.  Sterol O-acyltransferase 2 chaperoned by apolipoprotein J facilitates hepatic lipid accumulation following viral and nutrient stresses.

Authors:  Hung-Yu Sun; Tzu-Ying Chen; Yu-Ching Tan; Chun-Hsiang Wang; Kung-Chia Young
Journal:  Commun Biol       Date:  2021-05-12

10.  Plasma Clusterin and Lipid Profile: A Link with Aging and Cardiovascular Diseases in a Population with a Consistent Number of Centenarians.

Authors:  Angela Baralla; Elisabetta Sotgiu; Marta Deiana; Sara Pasella; Sara Pinna; Andrea Mannu; Elisabetta Canu; Giovanni Sotgiu; Antonello Ganau; Angelo Zinellu; Salvatore Sotgia; Ciriaco Carru; Luca Deiana
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.